Copyright
©The Author(s) 2023.
World J Gastroenterol. Feb 7, 2023; 29(5): 851-866
Published online Feb 7, 2023. doi: 10.3748/wjg.v29.i5.851
Published online Feb 7, 2023. doi: 10.3748/wjg.v29.i5.851
Figure 13 Interleukin-17 mRNA expression in the anastomotic mucosa.
A: Expression of interleukin (IL)-17 mRNA in the perianastomotic mucosa in all transgenic (Tg) and nontransgenic (nTg) groups at sacrifice; B: IL-17 mRNA expression between surgery [week (W) 12] and sacrifice (W18) in paired Tg rats receiving adherent-invasive Escherichia coli strain LF82 alone; C: IL-17 mRNA expression between W12 and W18 in paired Tg rats receiving coadministration of Saccharomyces cerevisiae (S. cerevisiae) CNCM I-3856 and LF82; D: IL-17 mRNA expression between W12 and W18 in paired Tg rats receiving S. cerevisiae CNCM I-3856 alone. aP < 0.05. β-act: β-actin; PBS: Phosphate buffered saline.
- Citation: Valibouze C, Speca S, Dubuquoy C, Mourey F, M'Ba L, Schneider L, Titecat M, Foligné B, Genin M, Neut C, Zerbib P, Desreumaux P. Saccharomyces cerevisiae prevents postoperative recurrence of Crohn's disease modeled by ileocecal resection in HLA-B27 transgenic rats. World J Gastroenterol 2023; 29(5): 851-866
- URL: https://www.wjgnet.com/1007-9327/full/v29/i5/851.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i5.851